Simris Group AB (PUBL) (STO:SIMRIS.B)
Sweden · Delayed Price · Currency is SEK 0.1130
-0.0080 (-6.61%)
Nov 2, 2026, 3:53 PM CET
Simris Group AB (PUBL) Market Cap
Simris Group AB (PUBL) has a market cap or net worth of 152.53 million as of November 2, 2026. It is the 38,099th most valuable company in the world and the 534th biggest in Sweden. Its market cap has increased by 146.95% in one year.
Market Cap
152.53M
Enterprise Value
144.54M
Revenue
1.39M
Global Rank
Country Rank
#534 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since April 22, 2016, Simris Group AB (PUBL)'s market cap has increased from 122.27M to 152.53M, an increase of 24.74%. That is a compound annual growth rate of 2.12%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 152.53M | 470.06% |
| Dec 30, 2025 | 26.76M | 0.88% |
| Dec 30, 2024 | 26.52M | -66.13% |
| Dec 29, 2023 | 78.32M | 72.71% |
| Dec 30, 2022 | 45.35M | -21.98% |
| Dec 30, 2021 | 58.12M | 3.20% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Xbrane Biopharma AB | 267.87M |
| Intervacc AB | 260.89M |
| Elicera Therapeutics AB | 178.19M |
| Diamyd Medical AB | 153.12M |
| Abera Bioscience AB | 140.62M |
| Xintela AB | 133.50M |
| Initiator Pharma | 128.35M |
| Alzinova AB | 108.25M |